Form 4: Penumbra President Granted 9,170 RSUs
Insider Transaction Report
Penumbra Inc. President Shruthi Narayan was granted 9,170 restricted stock units under the company's equity incentive plan.
Summary
- Shruthi Narayan, President of Penumbra Inc. (PEN), was granted 9,170 restricted stock units (RSUs).
- The grant occurred on September 15, 2025, under the Issuer's Amended and Restated 2014 Equity Incentive Plan.
- These RSUs have a vesting schedule where 1/4 will vest equally on an annual basis, commencing September 15, 2026.
- Vesting is contingent upon Shruthi Narayan's continued service to the company.
- Following this transaction, Shruthi Narayan beneficially owns 28,255 shares of Common Stock, a portion of which is subject to vesting.
Sentiment
Score: 7
Explanation: The grant of restricted stock units to a key executive is generally a positive signal for executive retention and alignment of interests with shareholders, though it doesn't directly reflect operational performance.
Positives
- Grant of 9,170 restricted stock units to a key executive, Shruthi Narayan, aligns management incentives with shareholder interests.
- The vesting schedule encourages long-term retention and continued service from the President.
Risks
- The vesting of the restricted stock units is subject to the reporting person's continued service, meaning the full benefit is not immediately realized if employment ceases.
Future Outlook
The vesting schedule for the granted restricted stock units indicates future equity compensation will be realized annually, contingent on continued service, starting September 15, 2026.
Industry Context
Equity grants to key executives like the President are a standard practice across the medical technology and healthcare industry to attract, retain, and incentivize top talent, aligning their interests with long-term company performance and shareholder value.
Comparison to Industry Standards
- The grant of restricted stock units with a multi-year vesting schedule is a common executive compensation practice, comparable to similar equity incentive plans observed in companies like Medtronic, Boston Scientific, or Stryker, which also utilize performance-based or time-based equity awards to incentivize their leadership.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The grant was made under the Issuer's Amended and Restated 2014 Equity Incentive Plan, indicating ongoing use of established compensation frameworks. | 09/15/2025 | Reinforces the company's commitment to using equity-based compensation to incentivize and retain key personnel, aligning executive interests with long-term shareholder value. |
Stakeholder Impact
- Shareholders: Potential positive impact due to increased executive alignment with long-term company performance and retention of key talent.
- Employees: May signal a stable and incentivized leadership team, potentially fostering a positive work environment.
- Management: Direct benefit through equity compensation, subject to vesting and continued service.
Next Steps
- Annual vesting of 1/4 of the granted RSUs will commence on September 15, 2026, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 09/15/2025 | Date of RSU grant transaction. |
| 09/16/2025 | Date the Form 4 was filed. |
| 09/15/2026 | First vesting date for the restricted stock units. |
Recommendation
holdThis Form 4 filing reports a routine grant of restricted stock units to a key executive, which is a standard compensation practice. While it indicates executive alignment and retention, it does not provide new financial performance data or strategic shifts that would warrant a change in investment recommendation based solely on this filing. Investors should consider broader financial reports and market conditions.
Keywords
Penumbra Inc, PEN, Shruthi Narayan, Restricted Stock Units, RSU, Insider Transaction, Equity Incentive Plan, Executive Compensation, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.